C. Loefgren

Patient characteristics and outcomes after ruxolitinib discontinuation in patients with myelofibrosis

J. Mascarenhas, M. Mehra, R. Potluri, 2020, Journal of medical economics.

Cost-Effectiveness Analyses, Costs and Resource Use, and Health-Related Quality of Life in Patients with Follicular or Marginal Zone Lymphoma: Systematic Reviews

N. Monga, C. Thieblemont, J. Quigley, 2020, PharmacoEconomics - Open.

Patient-reported outcomes predict overall survival in older patients with acute myeloid leukemia.

D. Cella, F. Efficace, J. Peipert, 2021, Journal of geriatric oncology.

Validation of the Functional Assessment of Cancer Therapy–Leukemia instrument in patients with acute myeloid leukemia who are not candidates for intensive therapy

D. Cella, S. Yount, F. Efficace, 2020, Cancer.

Patient-Reported Disease Burden in the Elderly Patients with Acute Myeloid Leukemia

X. Thomas, Renee Pierson, Jianming He, 2017 .